Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/in-vivo-changes-in-microglial-activation-and-amyloid-deposits-in-brain-0sU6x85EOr
References (45)
-
M. Watanabe, K. Shimizu, T. Omura, M. Takahashi, T. Kosugi, E. Yoshikawa, N. Sato, H. Okada, T. Yamashita (2001)
A new high resolution PET scanner dedicated to brain research2001 IEEE Nuclear Science Symposium Conference Record (Cat. No.01CH37310), 3
-
Keqiang Chen, P. Iribarren, Jinyue Hu, Jianhong Chen, W. Gong, Edward Cho, S. Lockett, N. Dunlop, Ji Wang (2006)
Activation of Toll-like Receptor 2 on Microglia Promotes Cell Uptake of Alzheimer Disease-associated Amyloid β Peptide*Journal of Biological Chemistry, 281
-
G. Mckhann, D. Drachman, M. Folstein, R. Katzman, D. Price, E. Stadlan (1984)
Clinical diagnosis of Alzheimer's diseaseNeurology, 34
-
M. Heneka, Magdalena Sastre, Lucia Dumitrescu-Ozimek, I. Dewachter, Jochen Walter, Thomas Klockgether, Fred Leuven (2005)
Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic miceJournal of Neuroinflammation, 2
-
S. Barger, A. Harmon (1997)
Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein ENature, 388
-
G. Shankar, Shaomin Li, Tapan Mehta, A. García-Muñoz, Nina Shepardson, Imelda Smith, F. Brett, Michael Farrell, M. Rowan, C. Lemere, C. Regan, D. Walsh, B. Sabatini, D. Selkoe (2008)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memoryNature Medicine, 14
-
P. Mcgeer, E. Mcgeer, J. Rogers, Jack Sibley (1990)
Anti-inflammatory drugs and Alzheimer diseaseThe Lancet, 335
-
J. Tan, T. Town, D. Paris, T. Mori, Zhiming Suo, F. Crawford, M. Mattson, R. Flavell, M. Mullan (1999)
Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation.Science, 286 5448
-
J. Price, W. Klunk, B. Lopresti, Xueling Lu, J. Hoge, S. Ziolko, D. Holt, C. Meltzer, S. DeKosky, C. Mathis (2005)
Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-BJournal of Cerebral Blood Flow & Metabolism, 25
-
P Edison, HA Archer, R Hinz, A Hammers, N Pavese, YF Tai (2007)
Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET studyNeurology, 68
-
M Watanabe, K Shimizu, T Omura, M Takahashi, T Kosugi, E Yoshikawa (2002)
A new high-resolution PET scanner dedicated to brain researchIEEE Trans Nucl Sci, 49
-
P. Edison, H. Archer, R. Hinz, A. Hammers, N. Pavese, Yen Tai, G. Hotton, D. Cutler, Nick Fox, A. Kennedy, M. Rossor, D. Brooks (2007)
Amyloid, hypometabolism, and cognition in Alzheimer diseaseNeurology, 68
-
N. Foster, Angela Wang, T. Tasdizen, P. Fletcher, J. Hoffman, R. Koeppe (2008)
Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer’s diseaseAlzheimer's & Dementia, 4
-
A. Lammertsma, S. Hume (1996)
Simplified Reference Tissue Model for PET Receptor StudiesNeuroImage, 4
-
A. Drzezga, T. Grimmer, G. Henriksen, I. Stangier, R. Perneczky, J. Diehl-Schmid, C. Mathis, W. Klunk, J. Price, S. DeKosky, H. Wester, M. Schwaiger, A. Kurz (2008)
Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer’s diseaseNeuroImage, 39
-
W. Klunk, H. Engler, A. Nordberg, Yanming Wang, G. Blomqvist, D. Holt, M. Bergström, I. Savitcheva, Guo-feng Huang, S. Estrada, Birgitta Ausén, M. Debnath, J. Barletta, J. Price, J. Sandell, B. Lopresti, A. Wall, P. Koivisto, G. Antoni, C. Mathis, B. Långström (2004)
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 55
-
John Hardy, D. Selkoe (2002)
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 297
-
H. Engler, A. Forsberg, O. Almkvist, G. Blomquist, E. Larsson, I. Savitcheva, A. Wall, Anna Ringheim, B. Långström, A. Nordberg (2006)
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.Brain : a journal of neurology, 129 Pt 11
-
K. Richard, M. Filali, Paul Préfontaine, S. Rivest (2008)
Toll-Like Receptor 2 Acts as a Natural Innate Immune Receptor to Clear Amyloid β1–42 and Delay the Cognitive Decline in a Mouse Model of Alzheimer's DiseaseThe Journal of Neuroscience, 28
-
S. Minoshima, B. Giordani, S. Berent, K. Frey, N. Foster, D. Kuhl (1997)
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's diseaseAnnals of Neurology, 42
-
G. Alexander, Kewei Chen, P. Pietrini, S. Rapoport, E. Reiman (2002)
Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.The American journal of psychiatry, 159 5
-
P. Edison, H. Archer, A. Gerhard, R. Hinz, N. Pavese, F. Turkheimer, A. Hammers, Yen Tai, Nick Fox, A. Kennedy, M. Rossor, D. Brooks (2008)
Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET studyNeurobiology of Disease, 32
-
T. Wyss-Coray (2006)
Inflammation in Alzheimer disease: driving force, bystander or beneficial response?Nature Medicine, 12
-
C. Malaplate‐Armand, Sabrina Florent-Béchard, Ihsen Youssef, V. Koziel, I. Sponne, B. Kriem, B. Leininger-muller, J. Olivier, T. Oster, T. Pillot (2006)
Soluble oligomers of amyloid-β peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathwayNeurobiology of Disease, 23
-
J. Jacobsen, Chi‐Cheng Wu, J. Redwine, T. Comery, Robert Arias, M. Bowlby, R. Martone, J. Morrison, M. Pangalos, P. Reinhart, F. Bloom (2006)
Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease.Proceedings of the National Academy of Sciences of the United States of America, 103 13
-
C. Wiley, B. Lopresti, S. Venneti, J. Price, W. Klunk, S. DeKosky, C. Mathis (2009)
Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease.Archives of neurology, 66 1
-
Y. Ouchi, E. Yoshikawa, H. Okada, M. Futatsubashi, Y. Sekine, M. Iyo, M. Sakamoto (1999)
Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: Compartment analysis for β‐CFT binding with positron emission tomographyAnnals of Neurology, 45
-
Y. Ouchi, S. Nobezawa, H. Okada, E. Yoshikawa, M. Futatsubashi, M. Kaneko (1998)
Altered glucose metabolism in the hippocampal head in memory impairmentNeurology, 51
-
S. Rosi, V. Ramírez-Amaya, A. Vazdarjanova, E. Esparza, P. Larkin, J. Fike, G. Wenk, C. Barnes (2009)
Accuracy of hippocampal network activity is disrupted by neuroinflammation: rescue by memantine.Brain : a journal of neurology, 132 Pt 9
-
K. Tahara, Hong-Duck Kim, Jingji Jin, J. Maxwell, Ling Li, K. Fukuchi (2006)
Role of toll-like receptor signalling in Abeta uptake and clearance.Brain : a journal of neurology, 129 Pt 11
-
G McKhann, D Drachman, M Folstein, R Katzman, D Price, EM Stadlan (1984)
Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s DiseaseNeurology, 34
-
C. Jack, V. Lowe, S. Weigand, H. Wiste, M. Senjem, D. Knopman, M. Shiung, J. Gunter, B. Boeve, B. Kemp, M. Weiner, R. Petersen (2009)
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's diseaseBrain, 132
-
Y. Ouchi, E. Yoshikawa, Y. Sekine, M. Futatsubashi, T. Kanno, Tomomi Ogusu, T. Torizuka (2005)
Microglial activation and dopamine terminal loss in early Parkinson's diseaseAnnals of Neurology, 57
-
J Talairach, P Tournoux (1988)
Co-planer stereotaxic atlas of the human brain: 3-dimensional proportional system: an approach to cerebral imaging -
M. Torrens (1990)
Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268Clinical Radiology, 41
-
I. Mackenzie (2001)
Postmortem studies of the effect of anti-inflammatory drugs on Alzheimer-type pathology and associated inflammationNeurobiology of Aging, 22
-
N. Scheinin, S. Aalto, J. Koikkalainen, J. Lötjönen, M. Karrasch, N. Kemppainen, M. Viitanen, K. Någren, S. Helin, M. Scheinin, J. Rinne (2009)
Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controlsNeurology, 73
-
A. Cagnin, D. Brooks, A. Kennedy, R. Gunn, R. Myers, F. Turkheimer, T. Jones, R. Banati, R. Banati (2001)
In-vivo measurement of activated microglia in dementiaThe Lancet, 358
-
A. Szczepanik, D. Rampe, G. Ringheim (2001)
Amyloid-beta peptide fragments p3 and p4 induce pro-inflammatory cytokine and chemokine production in vitro and in vivo.Journal of neurochemistry, 77 1
-
B. Lopresti, W. Klunk, C. Mathis, J. Hoge, S. Ziolko, Xueling Lu, C. Meltzer, Kurt Schimmel, N. Tsopelas, S. DeKosky, J. Price (2005)
Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 46 12
-
P. Lacor, Maria Buniel, Paul Furlow, Antonio Clemente, P. Velasco, M. Wood, K. Viola, W. Klein (2007)
Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's DiseaseThe Journal of Neuroscience, 27
-
Jeffrey Craft, D. Watterson, S. Frautschy, L. Eldik (2004)
Aminopyridazines inhibit β-amyloid-induced glial activation and neuronal damage in vivoNeurobiology of Aging, 25
-
R. Banati, J. Newcombe, R. Gunn, A. Cagnin, F. Turkheimer, F. Heppner, G. Price, F. Wegner, G. Giovannoni, D. Miller, G. Perkin, Terence Smith, A. Hewson, G. Bydder, G. Kreutzberg, T. Jones, M. Cuzner, R. Myers (2000)
The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity.Brain : a journal of neurology, 123 ( Pt 11)
-
Jun Tan, T. Town, F. Crawford, Takashi Mori, A. Delledonne, Robert Crescentini, Demian Obregon, R. Flavell, M. Mullan (2002)
Role of CD40 ligand in amyloidosis in transgenic Alzheimer's miceNature Neuroscience, 5
-
V. Leinonen, I. Alafuzoff, S. Aalto, T. Suotunen, S. Savolainen, K. Någren, T. Tapiola, T. Pirttilä, J. Rinne, J. Jääskeläinen, H. Soininen, J. Rinne (2008)
Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.Archives of neurology, 65 10
- Publisher
- Springer Journals
- Copyright
- Copyright © 2010 by Springer-Verlag
- Subject
- Medicine & Public Health; Oncology; Cardiology; Orthopedics; Imaging / Radiology; Nuclear Medicine
- ISSN
- 1619-7070
- eISSN
- 1619-7089
- DOI
- 10.1007/s00259-010-1612-0
- pmid
- 20844871
- Publisher site
- See Article on Publisher Site
Abstract
A lack of coupling between microglial activation and amyloid deposits may indicate that Aβ accumulation shown by ( 11 C)PIB is not always the primary cause of microglial activation, but rather the negative correlation present in the PCC suggests that microglia can show higher activation during the production of Aβ in early AD.
Journal
European Journal of Nuclear Medicine and Molecular Imaging – Springer Journals
Published: Sep 16, 2010